SEC Form 4 · accession 0001615774-15-001407
Vivani Medical, Inc. · VANI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Anne-Marie Juliette Ripley
Officer — VP Regulatory Affairs
Period of report
Jun 4, 2015
Accepted (ET)
Jun 8, 2015 · 5:19 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001266806
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| COMMON STOCKF1 | Jun 4, 2015 | M | 4,371 | $4.75 | A | 4,371 | D | |
| COMMON STOCKF2,F3 | Jun 4, 2015 | S | 4,371 | $15.00 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| OptionF3 | $4.75 | Jun 4, 2015 | M | 4,371 | D | — | Sep 1, 2015 | Common Stock | 4,371 | 0 | D |
| OptionF3 | $4.75 | holding | — | — | — | — | Jan 1, 2016 | Common Stock | 2,500 | 2,500 | D |
| OptionF3 | $5.00 | holding | — | — | — | — | Jan 1, 2017 | Common Stock | 6,125 | 6,125 | D |
| OptionF3 | $5.00 | holding | — | — | — | — | Apr 1, 2018 | Common Stock | 4,750 | 4,750 | D |
| OptionF3 | $5.00 | holding | — | — | — | — | Nov 1, 2018 | Common Stock | 25,000 | 25,000 | D |
| OptionF3 | $5.00 | holding | — | — | — | — | Feb 1, 2019 | Common Stock | 6,750 | 6,750 | D |
| OptionF3 | $5.00 | holding | — | — | — | — | Feb 1, 2020 | Common Stock | 10,125 | 10,125 | D |
| OptionF3 | $5.00 | holding | — | — | — | — | Feb 1, 2020 | Common Stock | 10,625 | 10,625 | D |
| OptionF3 | $5.00 | holding | — | — | — | — | Mar 1, 2021 | Common Stock | 8,313 | 8,313 | D |
| OptionF3 | $5.00 | holding | — | — | — | — | Mar 1, 2022 | Common Stock | 5,813 | 5,813 | D |
| OptionF3 | $5.00 | holding | — | — | — | — | Apr 1, 2024 | Common Stock | 3,125 | 3,125 | D |
Explanation of responses
- F1Ms. Ripley exercised 4,371 vested options (which expire on September 1, 2015) reported as Option(1) on Form 3 filed with the SEC on November 18, 2014.
- F2These transactions were effected pursuant to planned sales under lock-up agreement entered into at the time of EYES IPO in November 2014, as approved by Board of EYES and the IPO underwriter and as further disclosed in the Company's prospectus dated November 20, 2014.
- F3These are vested employee options currently exercisable.
Remarks
Excludes employee options, covering 89,781 shares, not exercisable for over 60 days from this date. Sales reported in this Form 4 constitute the final trades contemplated upon expiration of the six month lock-up noted in footnote 2 above, with the Reporting Person's share sales after this date remaining subject to a 12 month lock-up that commenced from the IPO date.